Takeda Pharmaceutical Co. Ltd. is to transfer the ownership of selected real estate assets in Japan - including its Osaka headquarters - to an undisclosed buyer to raise around JPY38bn ($347m) before tax ahead of the end of its current fiscal year on March 31.
The move, initially involving the formation of a new wholly owned subsidiary under existing Tokyo-based Takeda Pharmaceutical Real Estate (TPRE,...







